Valuation: Photocure ASA

Market Cap 1.5B 159M 137M 129M 117M 221M 15.24B 224M 1.52B 594M 7.62B 597M 584M 25.38B P/E 2026 *
19.6x
P/E 2027 * 71.3x
Enterprise Value 1.33B 141M 122M 115M 104M 196M 13.52B 199M 1.34B 527M 6.76B 530M 518M 22.52B EV / Sales 2026 *
2.02x
EV / Sales 2027 * 2.01x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day-2.34%
1 week+3.04%
Current month+2.45%
1 month-5.73%
3 months-17.10%
6 months-8.43%
Current year-23.95%
1 week 52.7
Extreme 52.7
60.5
1 month 46.25
Extreme 46.25
60.5
Current year 46.25
Extreme 46.25
79.8
1 year 46.25
Extreme 46.25
79.8
3 years 40.7
Extreme 40.7
79.8
5 years 40.7
Extreme 40.7
127.3
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 2018-10-31
Chief Tech/Sci/R&D Officer - 2021-07-31
Human Resources Officer - 2021-01-31
Director TitleAgeSince
Director/Board Member - 2021-12-31
Chairman - 2023-09-26
Director/Board Member - 2024-05-22
Date Insider Type Main position Quantity % Market Cap.
4/2/25 BuyCompany 11,355 0.0419%
4/2/25 BuyCompany 8,997 0.0332%
3/31/25 BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
-2.34%+3.04%-13.95%+30.53% 159M
+3.60%+0.88%+75.59%+124.32% 1,093B
+3.33%+4.35%+53.82%+57.17% 653B
+3.43%+3.53%+25.34%+72.45% 458B
+1.33%-0.25%+40.12%+43.37% 355B
+0.73%+1.59%+25.05%+40.20% 294B
+1.17%+1.97%+1.27%+11.79% 248B
+1.41%+2.65%+45.34%+62.43% 230B
-0.48%-1.47%-15.21%-53.20% 203B
+3.25%+5.65%+21.57%+89.04% 178B
Average +0.86%+1.75%+25.90%+47.81% 371.06B
Weighted average by Cap. +1.10%+1.45%+43.77%+68.95%

Financials

2026 *2027 *
Net sales 658M 69.95M 60.42M 56.85M 51.66M 97.17M 6.7B 98.6M 667M 261M 3.35B 263M 257M 11.17B 666M 70.8M 61.15M 57.54M 52.29M 98.35M 6.78B 99.8M 675M 264M 3.39B 266M 260M 11.3B
Net income 76.33M 8.11M 7.01M 6.59M 5.99M 11.27M 777M 11.43M 77.32M 30.3M 389M 30.45M 29.79M 1.29B 21M 2.23M 1.93M 1.81M 1.65M 3.1M 214M 3.15M 21.27M 8.34M 107M 8.38M 8.2M 356M
Net Debt -169M -17.96M -15.51M -14.59M -13.26M -24.95M -1.72B -25.31M -171M -67.08M -861M -67.42M -65.96M -2.87B -157M -16.68M -14.41M -13.56M -12.32M -23.17M -1.6B -23.51M -159M -62.32M -799M -62.63M -61.27M -2.66B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
26-08-19 NOK 54.30 -2.34% 78,204
26-08-18 NOK 55.60 -3.30% 96,514
26-08-17 NOK 57.50 +1.77% 320,703
26-08-14 NOK 56.50 +5.61% 349,944
26-08-13 NOK 53.50 +1.52% 58,141
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
55.60NOK
Average target price
79.67NOK
Spread / Average Target
+43.29%

Quarterly revenue - Rate of surprise